True positives · adults with presumptive pulmonary tuberculosis. Participants were unselected, meaning they were not enrolled in a study based on…
1 finding from 1 review
False negatives · adults with presumptive pulmonary tuberculosis. Participants were unselected, meaning they were not enrolled in a study based on…
1 finding from 1 review
True negatives · adults with presumptive pulmonary tuberculosis. Participants were unselected, meaning they were not enrolled in a study based on…
1 finding from 1 review
False positives · adults with presumptive pulmonary tuberculosis. Participants were unselected, meaning they were not enrolled in a study based on…
1 finding from 1 review
Test result · adults with presumptive pulmonary tuberculosis Role: an initial test Index tests: Xpert Ultra and Xpert MTB/RIF Threshold for index tests:…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
True positives · adults with presumptive pulmonary tuberculosis Role: an initial test Index tests: Xpert Ultra and Xpert MTB/RIF Threshold for index tests:…
1 finding from 1 review
False negatives · adults with presumptive pulmonary tuberculosis Role: an initial test Index tests: Xpert Ultra and Xpert MTB/RIF Threshold for index tests:…
1 finding from 1 review
True negatives · adults with presumptive pulmonary tuberculosis Role: an initial test Index tests: Xpert Ultra and Xpert MTB/RIF Threshold for index tests:…
1 finding from 1 review
Maternal parasitaemia (at delivery) · HIV‐infected pregnant women
Mefloquine plus cotrimoxazole probably leads to lower maternal peripheral parasitaemia at delivery (PCR) compared with cotrimoxazole (moderate certainty).
1 finding from 1 review
Placental malaria · HIV‐infected pregnant women
Mefloquine plus cotrimoxazole probably leads to lower placental malaria (PCR) compared with cotrimoxazole (moderate certainty).
1 finding from 1 review
Maternal anaemia at delivery · HIV‐infected pregnant women
Mefloquine plus cotrimoxazole showed no clear difference in maternal anaemia at delivery compared with cotrimoxazole (moderate certainty).
1 finding from 1 review
Low birthweight · HIV‐infected pregnant women
Mefloquine plus cotrimoxazole showed no clear difference in low birth weight compared with cotrimoxazole (moderate certainty).
1 finding from 1 review
Spontaneous abortions and stillbirths · HIV‐infected pregnant women
It is very uncertain whether mefloquine plus cotrimoxazole changes spontaneous abortions and stillbirths compared with cotrimoxazole (very low certainty).
1 finding from 1 review
Vomiting · HIV‐infected pregnant women
Mefloquine plus cotrimoxazole leads to higher AEs: vomiting compared with cotrimoxazole (high certainty).
1 finding from 1 review
Dizziness · HIV‐infected pregnant women
Mefloquine plus cotrimoxazole leads to higher AEs: dizziness compared with cotrimoxazole (high certainty).
1 finding from 1 review
Maternal parasitaemia (at delivery) · HIV‐uninfected pregnant women
Mefloquine leads to lower maternal peripheral parasitaemia at delivery compared with sulfadoxine‐pyrimethamine (high certainty).
1 finding from 1 review
Placental malaria · HIV‐uninfected pregnant women
Mefloquine showed no clear difference in placental malaria compared with sulfadoxine‐pyrimethamine (low certainty).
1 finding from 1 review
Maternal anaemia at delivery · HIV‐uninfected pregnant women
Mefloquine probably leads to lower maternal anaemia at delivery compared with sulfadoxine‐pyrimethamine (moderate certainty).
1 finding from 1 review
Low birthweight · HIV‐uninfected pregnant women
Mefloquine showed no clear difference in low birth weight compared with sulfadoxine‐pyrimethamine (high certainty).
1 finding from 1 review
Spontaneous abortions and stillbirths · HIV‐uninfected pregnant women
Mefloquine showed no clear difference in stillbirths and abortions compared with sulfadoxine‐pyrimethamine (moderate certainty).
1 finding from 1 review